Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE

156.100
+1.2000.77%
Volume:4.67M
Turnover:721.11M
Market Cap:240.24B
PE:-42.24
High:156.500
Open:156.400
Low:151.400
Close:154.900
Loading ...

BeiGene Changes Name to BeOne Medicines, Completes Redomiciliation to Switzerland

MT Newswires Live
·
27 May

BeiGene's Tevimbra Gets Positive Opinion from Committee for Medicinal Products for Human Use

Dow Jones
·
27 May

Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication

MT Newswires Live
·
23 May

Market Chatter: Hillhouse Cashes In on BeiGene Rally; Backs Hengrui Pharma IPO

MT Newswires Live
·
16 May

BeiGene to Issue 133 Million Shares to Unit for Award Scheme

MT Newswires Live
·
15 May

Market Chatter: WuXi AppTec Chairman Tops China's A-List for Highest Pay in 2024

MT Newswires Live
·
09 May

BeiGene Is Maintained at Buy by Guggenheim

Dow Jones
·
08 May

RBC Trims Price Target on BeiGene to $311 From $312, Keeps Outperform Rating

MT Newswires Live
·
08 May

BeiGene Turns to Q1 Profit

MT Newswires Live
·
08 May

BeiGene Narrows Q1 Loss as Operating Income Jumps 50%

MT Newswires Live
·
08 May

Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat

Benzinga
·
07 May

BeiGene Swings to Q1 Adjusted Earnings, Revenue Increases; 2025 Revenue Outlook Reiterated

MT Newswires Live
·
07 May

CORRECTION: BeiGene Q1 Adj. EPADS $1.22 Beats $(0.74) Estimate, Sales $1.12B Miss $1.14B Estimate

Benzinga
·
07 May

BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect Operation

Reuters
·
30 Apr

Beigene Says Pharmacyclics Litigation Is Not Having Adverse Effect on Development, Sales of Brukinsa in U.S.

THOMSON REUTERS
·
30 Apr

BeiGene Price Target Maintained With a $312.00/Share by RBC Capital

Dow Jones
·
28 Apr

BeiGene Is Maintained at Overweight by JP Morgan

Dow Jones
·
22 Apr

BeiGene Price Target Maintained With a $348.00/Share by Guggenheim

Dow Jones
·
10 Apr

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
09 Apr

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live
·
09 Apr